JURNAL INTERNASIONAL

References

1.     Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer incidence and mortality world-wide: IARC CancerBase No. 10 [Internet]. Lyon, France: Inter-national Agency for Research on Cancer; 2010. Available from:  http://globocan.iarc.fr [accessed 12/07/2012].

2.    United Nations, Population division. World population prospects, the 2010 revision. Available from:  http://www.un.org/esa/popula- tion/unpop.htm [accessed 12/09/2011].

3.    Jensen OM, Este`ve J, Møller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990;26:1167–256.

4.    Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33:1075–107.

5.    Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.

6.    Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16(3):481–8.

7.    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Cancer incidence and mortality in Europe, 2006. Ann Oncol 2007;16(3):481–8.

8.    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46(4):765–81.

9.    World Health Organization (WHO) Databank. Geneva, Switzer-land: WHO Statistical Information System. Available from: < http://www.who.int/whosis> [accessed July 2012].

10.     Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Comber H, Bray F. European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer. Available from:  http://eco.iarc.fr [accessed 14/09/2012].

11.      World Health Organization. International statistical classification of diseases and related health problems. Tenth revision, vol. 2. Geneva, Switzerland: WHO; 1993.

12.     Nordpred. A software for predicting trends in cancer incidence. Available from:  http://www.kreftregisteret.no/en/Research/Pro- jects/Nordpred/ [accessed 18/11/2011].

13.     Dyba T, Hakulinen T. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 2000;19(13):1741–52.

14.      Projection de l’incidence et de la mortalite´ par cancer en France en 2011. Rapport technique. Saint-Maurice: Institut de veille sani-taire; 2011. p. 78. Available from:  http://www.invs.sante.fr>.

15.     Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report. Berlin, Germany: Springer-Verlag (for UICC); 1966.

16.     Cancer registry Federation of Bosnia and Herzegovina. Overview of malignant neoplasms 2009. Institute for Public Health of Federation of Bosnia and Herzegovina, 2011.

J. Ferlay et al. / European Journal of Cancer 49 (2013) 1374–1403

1403

17.      Lutz JM, Pury P, Fioretta G, Raymond L. The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 2004;13(1):77–81.

18.      Pavillon G, Boileau J, Renaud G, et al. Conse´quences des changements de codage des causes me´dicales de de´ce`s sur les donne´es nationales de mortalite´ en France, a` partir de l’anne´e 2000. Bull Epidemiol Hebd 2005;4:13–6.

19.      Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer 2004;40:2794–803.

20.     Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diag-nosed in 1995–1999. Results and commentary, the EUROCARE Working Group. Eur J Cancer 2009;45:931–91.

21.      Cancer in Ukraine 2009-2010. Bulletin of National Cancer Registry of Ukraine No. 12. Kiev; 2011. Available from:  http://  users.iptelecom.net.ua/~ucr/ [accessed 03-07-2012].

22.     Swiss Federal Statistical Office. Cause of death statistics FSO – The Statistical Encyclopedia.

23.     Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, version 5.1 (March 2012). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from  http://  www.ancr.nu [accessed 11/06/2012.

24.     Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from:  http://ci5.iarc.fr.

25.     Curado MP, Edwards B, Shin HR, et al. (Eds.), Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007.

26.      Finnish Cancer Registry. Cancer in Finland 2008 and 2009. Cancer Society of Finland Publication No. 84, Helsinki; 2011.

27.     Registre Morphologique des Tumeurs au Grand – Duche´ de Luxembourg. Available from:  http://www.cancer-registry.lu [accessed 25/06/2012].

28.     Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2012. Ann Oncol 2012;23(4):1044–52, Epub 2012 Feb 28.

29.     International Agency for Research on Cancer (IARC). Mono-graphs on the evaluation of carcinogenic risks to humans, vol 83. Tobacco smoke and involuntary smoking. Lyon, France: IARC; 2004.

30.     Bray F, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007. Int J Cancer 2010;126(6):1454–66.

31.      Soerjomataram I, de Vries E, Pukkala E, Coebergh JW. Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int J Cancer 2007;120(6):1336–43.

32.      World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. Washington: World Cancer Research Fund/American Institute for Cancer Research; 1997.

33.     Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: European Commission, Publications Office of the European Union; 2010.

34.     Soerjomataram I, Pukkala E, Brenner H, Coebergh JW. On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 2008;111(2):297–302, Epub 2007 Oct 12.

35.     He´ry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008;19(6):1187–94.

36.     Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44(10):1345–89.

37.     Moss SM, Nystro¨m L, Jonsson H, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 2012:19.

38.     Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010;46(17):3040–52.

39.     Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652–61.

40.     Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer – part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999;16:91(12):1025–32.

41.     Hakulinen T, Arbyn M, Brewster DH, et al. Harmonization may be counterproductive – at least for parts of Europe where public health research operates effectively. Eur J Public Health 2011;21(6):686–7, Epub 2011 Nov 10.